Evidence map›Paper›PMID 35328372›Full record

ArticleInternational journal of molecular sciences2022

2-Aminoimidazoles Inhibit

Juan M Belardinelli, Wei Li, Kevin H Martin, Michael J Zeiler, Elena Lian, Charlotte Avanzi, Crystal J Wiersma, Tuan Vu Nguyen, Bhanupriya Angala, Vinicius C N de Moura and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Critical reviews in microbiology · 2026
    Review
  2. Article
  3. A laboratory perspective onFrontiers in microbiology · 2024
    Review
  4. Characterization ofAntimicrobial agents and chemotherapy · 2023
    Article
  5. Alternatives to Antibiotics againstAntibiotics (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Juan M BelardinelliMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.ORCID 0000-0003-1336-9141
Wei LiMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Kevin H MartinDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Michael J ZeilerDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA.
Elena LianMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Charlotte AvanziMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.ORCID 0000-0002-1062-4058
Crystal J WiersmaMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Tuan Vu NguyenDepartment of Chemistry, North Carolina State University, Raleigh, NC 27607, USA.
Bhanupriya AngalaMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Vinicius C N de MouraMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Victoria JonesMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Bradley R BorleeDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Christian MelanderDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA.
Mary JacksonMycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.

Funding

Zeiss LSM 510 Laser Scanning MicroscopeS10RR023735 · NCRR · COLORADO STATE UNIVERSITY · PI GONZALEZ-JUARRERO, MERCEDES · 2007 to 2007
$437k
Adjunct therapeutic potential of a repurposed drug inhibiting Mycobacterium abscessus biofilm formationR21AI147326 · NIAID · COLORADO STATE UNIVERSITY · PI JACKSON, MARY · 2020 to 2021
$418k
Cystic Fibrosis Foundation JACKSO18G0Cystic Fibrosis Trust 2017-SRC 010Marie Sklodowska-Curie grant 845479NIAID NIH HHS R21 AI147326NIH HHS 1 S10 RR023735-01NIH HHS AI147326Vertex Research Innovation Award N/A
6 · The paper itself

Abstract

Biofilm growth is thought to be a significant obstacle to the successful treatment of

Indexed as

Mycobacterium abscessusMycobacterium Infections, NontuberculousAnti-Bacterial AgentsBiofilmsHumansImidazolesMicrobial Sensitivity TestsZinc2-aminoimidazoleAnti-Bacterial AgentsImidazolesZinc2-aminoimidazolesbiofilmMycobacterium abscessusnontuberculous mycobacteriazinc

Identifiers

PMID35328372
PMCPMC8951752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.